Oxethazaine
CAS No. 126-27-2
Oxethazaine( Oxethazaine | WY 806 | Wy-806 | Oxetacaine | Emoren | FH 099 )
Catalog No. M11096 CAS No. 126-27-2
Oxethazaine is a topical anesthetic, in preventing acid-induced esophageal pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 37 | In Stock |
|
| 100MG | 59 | In Stock |
|
| 200MG | 85 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOxethazaine
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxethazaine is a topical anesthetic, in preventing acid-induced esophageal pain.
-
DescriptionOxethazaine is a topical anesthetic, in preventing acid-induced esophageal pain.(In Vivo):Oxetacaine (intraperitoneal injection; 5, 10, and 15 mg/kg; during days 4–11) doses induces significant conditioned place preference (CPP), and there are no differences among the groups. While its postive control group phentermine only 3 mg/kg causes significant CPP. .
-
In Vitro——
-
In VivoOxetacaine (intraperitoneal?injection; 5, 10, and 15 mg/kg; during days 4–11) doses induces significant conditioned place preference (CPP), and there are no differences among the groups. While its postive control group phentermine only 3 mg/kg causes significant CPP.. Animal Model:Male Wistar rats Dosage:5, 10, and 15 mg/kg; during days 4–11Administration:Intraperitoneal?injection Result:Showed a significant CPP in vivo.
-
SynonymsOxethazaine | WY 806 | Wy-806 | Oxetacaine | Emoren | FH 099
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number126-27-2
-
Formula Weight467.64
-
Molecular FormulaC28H41N3O3
-
Purity>98% (HPLC)
-
SolubilitySoluble in DMSO
-
SMILESOCCN(CC(N(C(C)(C)CC1=CC=CC=C1)C)=O)CC(N(C(C)(C)CC2=CC=CC=C2)C)=O
-
Chemical NameAcetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee SY, et al. Pharmacol Biochem Behav. 2013 Apr;105:98-104.
molnova catalog
related products
-
DSP-2230
DSP-2230 is a selective blocker of Nav1.7/Nav1.8.
-
AZD 7009 B
AZD 7009 is a novel antiarrhythmic compound that inhibits the sodium current of hNav1.5 in CHO K1 cells with an IC50 of 11 uM.
-
CNV1014802
CNV1014802 (GSK-1014802, Raxatrigine, Vixotrigine, BIIB074) is a potent, selective Nav1.7 sodium channel blocker.
Cart
sales@molnova.com